If India is becoming a favourite destination for clinical trials, Maharashtra is the hub with Mumbai and Pune accounting for the largest number of clinical trials in the country. Maharashtra alone accounted for well over a quarter of all the clinical trials registered with the clinical trials registry of India till 2010. A study of the trials recorded in the registry, done by the Centre for Studies in Ethics and...

Every afternoon at about four, a slight woman named Runi slips out of the cramped, airless room that she shares with her husband and their sixteen children. She skirts the drainage ditch in front of the building, then walks toward the pile of hardened dung cakes that people in this slum on the edge of the northeastern Indian city of Patna use for fuel. Dressed in a bright-yellow sari shot...

A patent is an artificial property right; it is created by the government, and would not exist if there were no government or if it did not grant patents. It is then for the government to decide whether to grant a patent or not. But a government would not normally make the decision arbitrarily; it would follow some rules. The rules universally followed are novelty, non-obviousness and commercial value. A...

MONA SANGWAN, a teacher at a private school in Delhi, who earns just Rs. 4,000 a month and is her family’s sole earning member, had nearly begun to despair. How on earth was she going to raise Rs. 7,000 every month to buy the medicines her brother Ashwini, a kidney transplant patient, needed? Mona would have continued to despair had not the NGO Sarvohit Social Welfare Society stepped in. And to...

Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical...